Temozolomide and Bleeding into the skin - a phase IV clinical study of FDA data

Summary:

Bleeding into the skin is reported as a side effect among people who take Temozolomide (temozolomide), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Bactrim, and have Neuroblastoma recurrent.

The phase IV clinical study analyzes which people have Bleeding into the skin when taking Temozolomide. It is created by eHealthMe based on reports of 16,598 people who have side effects when taking Temozolomide from the FDA, and is updated regularly.

What is Temozolomide?

Temozolomide has active ingredients of temozolomide. It is often used in glioblastoma multiforme. eHealthMe is studying from 16,644 Temozolomide users. Check the latest studies of Temozolomide.

What is Bleeding into the skin?

Bleeding into the skin is found to be associated with 937 drugs and 1,911 conditions by eHealthMe. Check the latest studies of Bleeding into the skin.

On Apr, 23, 2026

16,598 people reported to have side effects when taking Temozolomide.
Among them, 71 people (0.43%) have Bleeding into the skin.

Could Temozolomide cause Bleeding into the skin?

Among these 71 people:

How long have people been on Temozolomide when they have Bleeding into the skin? *

What is the gender of people who have Bleeding into the skin when taking Temozolomide? *

female: 73.53 %
male: 26.47 %

What is the age of people who have Bleeding into the skin when taking Temozolomide? *

What are other drugs people take besides Temozolomide? *

What are other side effects people have besides Bleeding into the skin? *

Thrombocytopenia (decrease of platelets in blood): 42 people, 59.15%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 15 people, 21.13%
Nosebleed (bleeding from nose): 14 people, 19.72%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 14 people, 19.72%
Fever: 12 people, 16.90%
Ecchymosis (a discoloration of the skin resulting from bleeding underneath): 12 people, 16.90%
Idiopathic Thrombocytopenic Purpura (Itp) (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 10 people, 14.08%
Gingival Bleeding (bleeding gums): 10 people, 14.08%
Weakness: 9 people, 12.68%
Bone Marrow Failure: 9 people, 12.68%

What are the existing conditions these people have? *

Neuroblastoma Recurrent (reoccurrence of a cancer that forms in your nerve tissue): 10 people, 14.08%
Brain Neoplasm Malignant (brain cancer tumour): 4 people, 5.63%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 4.23%
Ovarian Cancer (cancer of ovary): 3 people, 4.23%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 2 people, 2.82%
Anaplastic Astrocytoma (tumour of the glial (supportive) tissue of the brain): 2 people, 2.82%
Brain Neoplasm (tumour of brain): 2 people, 2.82%
Gout (uric acid crystals building up in the body): 2 people, 2.82%
Neuroblastoma (a cancer that forms in your nerve tissue): 2 people, 2.82%
Leiomyosarcoma (a very rare soft tissue sarcoma (cancer) that grows in muscle tissue): 1 person, 1.41%

* Approximation only. Some reports may have incomplete information.

Do you take Temozolomide and have Bleeding into the skin?

- Check whether Bleeding into the skin is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Temozolomide:

Temozolomide (16,644 reports)

Browse all side effects of Temozolomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bleeding into the skin:

Bleeding into the skin (937 drugs)

Browse all the conditions that are associated with Bleeding into the skin:

Bleeding into the skin (1,911 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on temozolomide (the active ingredients of Temozolomide) and Temozolomide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.